Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN


NEW YORK, April 20, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Supernus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On April 8, 2024, Supernus issued a press release announcing that "[t]he FDA has issued a Complete Response Letter (CRL) in response to the Company's New Drug Application (NDA) for SPN-830", the Company's investigational apomorphine infusion device for the continuous treatment of motor fluctuations ("off" episodes) in Parkinson's disease. The press release stated that "[t]he CRL indicates that the review cycle for the application is complete, but that the application is not ready for approval in its present form." Specifically, "[t]he CRL mentions two areas that require additional review by the FDA or additional information to be provided to the FDA", respectively relating to product quality and the master file for the infusion device.

On this news, Supernus's stock price fell $2.12 per share, or 6.32%, to close at $31.43 per share on April 8, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 12:29
The Honourable Randy Boissonnault, Minister of Employment, Workforce Development and Official Languages, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, will be in Edmonton to highlight support...

at 12:24
Leith Wheeler Investment Counsel Ltd., manager of the Leith Wheeler Investment Funds, announces today that it has been receipted for its simplified prospectus in all provinces and territories of Canada for the following funds: Leith Wheeler Balanced...

at 12:20
Transaction in Own Shares 30 May, 2024 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Shell plc (the ?Company') announces that on 30 May, 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to...

at 12:16
The following issues have been halted by CIRO Company: HIVE Digital Technologies Ltd. TSX-Venture Symbol: HIVE.WT All Issues: No Reason: Pending Delisting Halt Time (ET): 12:00 pm CIRO can make a decision to impose a temporary suspension (halt) of...

at 12:10
The vibrant city of Berlin is set to host an exciting array of events during the UEFA European Championship 2024, transforming the city into a hub of culture, sports, and sustainability. From June 14 to July 14, 2024, Berlin will not only be a key...

at 12:03
Today, Dialogue announces the launch of its innovative app designed for the creation and monetization of AI-powered digital clones and imaginary characters. The app enables influencers, content creators, actors, celebrities, and educators to build...



News published on and distributed by: